Insider Trading activities of Hyperion Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hyperion Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hyperion Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Hyperion Therapeutics Inc since 2005. The reporting company's ticker symbol is HPTX. The reporting company's CIK number is 1386858.
The total value of stock buying since 2005 is $67,199,260.
The total value of stock sales since 2005 is $34,142,943.
The total value of stock option exercises since 2005 is $2,647,347.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Hyperion Therapeutics Inc (HPTX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-05 0 $0 0 $0 478,896 $2,124,071
2015-03 0 $0 39,900 $1,371,472 20,000 $81,600
2015-02 0 $0 29,800 $897,278 0 $0
2015-01 0 $0 5,000 $124,075 0 $0
2014-12 0 $0 0 $0 1,093 $4,459
2014-10 0 $0 0 $0 15,021 $41,394
2014-07 0 $0 200 $5,600 0 $0
2014-06 0 $0 842,119 $23,301,951 15,696 $89,388
2014-04 0 $0 0 $0 5,232 $29,796
2014-03 0 $0 28,725 $859,865 15,000 $19,200
2014-01 0 $0 10,000 $240,902 22,858 $63,951
2013-09 0 $0 82,219 $2,159,628 0 $0
2013-08 0 $0 72,245 $1,834,714 0 $0
2013-05 0 $0 148,821 $3,347,458 16,682 $95,003
2012-11 0 $0 0 $0 10,384 $42,366
2012-10 0 $0 0 $0 43,843 $56,119
2012-07 6,719,926 $67,199,260 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Hyperion Therapeutics Inc insiders (HPTX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-05-01 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 59,087 4.22 249,524
2015-05-01 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 6,975 5.70 39,722
2015-05-01 Farrow Jeffrey S (CFO) Option Ex 120,777 4.98 601,469
2015-05-01 Santel Donald J (CEO & President) Option Ex 292,057 4.22 1,233,356
2015-03-17 Nash Christine A (SVP & Chief Commercial Officer) Sale 10,000 37.56 375,600
2015-03-17 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 10,000 4.08 40,800
2015-03-10 Nash Christine A (SVP & Chief Commercial Officer) Sale 11,450 32.59 394,445
2015-03-10 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 10,000 4.08 40,800
2015-03-09 Nash Christine A (SVP & Chief Commercial Officer) Sale 8,450 29.66 250,627
2015-02-27 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Sale 29,800 30.11 897,278
2015-01-20 Nash Christine A (SVP & Chief Commercial Officer) Sale 5,000 24.82 124,075
2014-12-23 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 1,093 4.08 4,459
2014-10-20 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 5,021 5.70 28,594
2014-10-15 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 10,000 1.28 12,800
2014-07-02 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Sale 200 28.00 5,600
2014-06-18 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 10,464 5.70 59,592
2014-06-06 Drant Ryan D (10% Owner) Sale 1,134 26.90 30,505
2014-06-06 Baskett Forest (10% Owner) Sale 1,377 26.89 37,022
2014-06-06 Kolluri Krishna Kittu (10% Owner) Sale 120 27.19 3,262
2014-06-06 Sandell Scott D (10% Owner) Sale 1,430 13.37 19,119
2014-06-06 Barrett M James (10% Owner) Sale 1,430 26.82 38,356
2014-06-06 Barris Peter J (10% Owner) Sale 1,134 26.90 30,505
2014-06-04 Healy James (Director) Sale 417,747 27.70 11,571,591
2014-06-04 Powell Michael (10% Owner) Sale 417,747 27.70 11,571,591
2014-04-01 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 5,232 5.70 29,796
2014-03-06 Nash Christine A (SVP & Chief Commercial Officer) Sale 5,100 29.54 150,643
2014-03-06 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 15,000 1.28 19,200
2014-03-04 Sofinnova Management Vii, L.l.c. (10% Owner) Sale 23,625 30.02 709,222
2014-01-14 Nash Christine A (SVP & Chief Commercial Officer) Sale 1,100 24.01 26,412
2014-01-14 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 6,100 1.28 7,808
2014-01-10 Nash Christine A (SVP & Chief Commercial Officer) Sale 8,900 24.10 214,490
2014-01-10 Nash Christine A (SVP & Chief Commercial Officer) Option Ex 8,900 1.28 11,392
2014-01-06 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 7,858 5.70 44,751
2013-09-20 Highland Capital Partners Vii Lp (10% Owner) Sale 4,300 25.81 110,983
2013-09-19 Highland Capital Partners Vii Lp (10% Owner) Sale 1,454 25.93 37,702
2013-09-18 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 5,770 26.03 150,193
2013-09-17 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 9,774 25.99 254,026
2013-09-16 Highland Capital Partners Vii Lp (10% Owner) Sale 6,200 26.22 162,564
2013-09-13 Highland Capital Partners Vii Lp (10% Owner) Sale 2,100 26.50 55,650
2013-09-11 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 4,573 27.08 123,836
2013-09-10 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 30,000 26.48 794,400
2013-09-09 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 17,948 26.06 467,724
2013-09-06 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 100 25.50 2,550
2013-08-05 Highland Management Partners Vii Limited Partnership (10% Owner) Sale 25,000 25.48 637,000
2013-08-02 Highland Capital Partners Vii Lp (10% Owner) Sale 2,707 25.37 68,676
2013-08-01 Highland Capital Partners Vii Lp (10% Owner) Sale 44,538 25.35 1,129,038
2013-05-30 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 5,366 21.00 112,686
2013-05-28 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 12,000 21.08 252,959
2013-05-22 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 16,682 5.70 95,003
2013-05-20 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 2,000 22.24 44,480
2013-05-17 Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) Sale 129,455 22.69 2,937,333
2012-11-20 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 10,384 4.08 42,366
2012-10-31 Scharschmidt Bruce Frederick (SVP & Chief Medical Officer) Option Ex 43,843 1.28 56,119
2012-07-31 Highland Management Partners Vii Limited Partnership (10% Owner) Buy 100,000 10.00 1,000,000
2012-07-31 Aggarwal Gaurav (Director) Buy 5,000 10.00 50,000
2012-07-31 Panorama Capital, L.p. (10% Owner) Buy 550,000 10.00 5,500,000
2012-07-31 Sofinnova Management Vii, L.l.c. (10% Owner) Buy 563,000 10.00 5,630,000
2012-07-31 Nea 12 Gp, Llc (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Drant Ryan D (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Baskett Forest (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Kolluri Krishna Kittu (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Sandell Scott D (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Kerins Patrick J (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Barrett M James (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Perry Mark W (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Barris Peter J (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Kramlich C Richard (10% Owner) Buy 500,000 10.00 5,000,000
2012-07-31 Newhall Charles W Iii (10% Owner) Buy 500,000 10.00 5,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of HPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hyperion Therapeutics Inc (symbol HPTX, CIK number 1386858) see the Securities and Exchange Commission (SEC) website.